started · updated
Zuellig Pharma Secures Cialis Rights from Eli Lilly for Singapore and 12 Asian Markets
Zuellig Pharma, a leading Asian healthcare solutions company, announced on 3 August 2026 that it has acquired all rights, title and interest in Cialis® (tadalafil) from Eli Lilly and Company in Singapore. The deal gives Zuellig ownership of the trademarks, marketing authorisations and manufacturing know‑how for the erectile‑dysfunction and benign prostatic hyperplasia treatment across twelve Asian markets, with continued promotion and distribution by the company.
The acquisition is part of Zuellig Pharma’s strategy to expand its portfolio of owned healthcare products. CEO John Graham said the move reflects the firm’s expertise in growing world‑class brands and its purpose to make essential healthcare more accessible to communities across Asia. Zuellig Pharma now serves more than 200,000 medical facilities, operates in 18 markets, employs over 12,000 staff and works with more than 450 clients.
Entities
Cialis · Eli Lilly and Company · John Graham · Singapore · Zuellig Pharma
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] The acquisition gives Zuellig Pharma ownership of trademarks, marketing authorisations and manufacturing know‑how for Cialis in 12 Asian markets. panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] Zuellig Pharma operates in 18 markets, employs over 12,000 staff, serves more than 200,000 medical facilities and works with over 450 clients. panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] The acquisition expands Zuellig Pharma’s product portfolio in Asia. panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] Zuellig Pharma acquired all rights, title and interest in Cialis® (tadalafil) from Eli Lilly in Singapore. panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] The acquisition aligns with Zuellig Pharma’s strategic priority to build a strong portfolio of owned healthcare products. panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] John Graham is the CEO of Zuellig Pharma and said the acquisition reflects the company’s expertise and purpose to make healthcare more accessible. panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] Cialis is a treatment for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). panafricanvisions.com · livenews.co.nz · vir.com.vn
- [● 3 SOURCES] Zuellig Pharma will continue to promote and distribute Cialis in the 12 Asian markets. panafricanvisions.com · livenews.co.nz · vir.com.vn